Table 4.
CHA2DS2‐VAS score 0, 1 (n=6698) | CHA2DS2‐VAS score 2, 3 (n=18 961) | CHA2DS2‐VAS score ≥4 (n=39 002) | Total (N=64 661) | ||
---|---|---|---|---|---|
Ischemic stroke and systemic embolism | No. of events | 33 | 189 | 928 | 1150 |
Incident rate | 0.33 | 0.72 | 1.82 | 1.32 | |
Ischemic stroke | No. of events | 28 | 157 | 808 | 993 |
Incident rate | 0.28 | 0.6 | 1.59 | 1.14 | |
Systemic embolism | No. of events | 5 | 32 | 120 | 157 |
Incident rate | 0.05 | 0.12 | 0.24 | 0.18 | |
Major bleeding | No. of events | 73 | 537 | 2629 | 3239 |
Incident rate | 0.74 | 2.04 | 5.16 | 3.72 | |
Gastrointestinal bleeding | No. of events | 47 | 337 | 1838 | 2222 |
Incident rate | 0.47 | 1.28 | 3.61 | 2.55 | |
Intracranial hemorrhage | No. of events | 10 | 98 | 479 | 587 |
Incident rate | 0.10 | 0.37 | 0.90 | 0.67 | |
Other bleeding | No. of events | 16 | 102 | 312 | 430 |
Incident rate | 0.16 | 0.39 | 0.61 | 0.49 |
CHA 2 DS 2‐VASc, risk based on the presence of congestive heart failure, hypertension, age ≥75 y, diabetes mellitus, prior stroke or transient ischemic attack, vascular disease, sex category.